Back to Journals » Journal of Hepatocellular Carcinoma » Volume 9

Original Research

Regorafenib Combined with PD-1 Blockade Immunotherapy versus Regorafenib as Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Study

       
Total article views   HTML views PDF downloads Totals
7,375 Dovepress* 6,479+ 416 6,895
PubMed Central* 896 434 1,330
Totals 7,375 850 8,225
*Since 10 March 2022
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed and Google Scholar